Drug Type Contrast agent, Small molecule drug |
Synonyms AngioMARK, Gadofosveset, Gadofosveset trisodium (USAN) + [9] |
Target- |
Mechanism Magnetic resonance imaging enhancers |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date EU (03 Oct 2005), |
Regulation- |
Molecular FormulaC33H40GdN3NaO15P |
InChIKeyPCCSSUXRRXTZNY-UHFFFAOYSA-H |
CAS Registry211570-55-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D04286 | Gadofosveset Trisodium |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Peripheral Vascular Diseases | US | 22 Dec 2008 | |
Cardiovascular Diseases | CA | 05 Feb 2008 | |
Vascular Diseases | EU | 03 Oct 2005 | |
Vascular Diseases | IS | 03 Oct 2005 | |
Vascular Diseases | LI | 03 Oct 2005 | |
Vascular Diseases | NO | 03 Oct 2005 |
Phase 4 | 17 | (Ferumoxytol) | crysbcdsbu(xvobzigeat) = xxoxosezpl vmakpcptwm (liezdofwln, jsjzavwgqp - hjqjgzdxsg) View more | - | 28 Dec 2022 | ||
(Gadofosveset) | crysbcdsbu(xvobzigeat) = ofykauxtbj vmakpcptwm (liezdofwln, pdlihgmfmc - jpzvdrarwg) View more | ||||||
Phase 2 | 20 | gwjzhuvxem(qvwazobgvu) = fcsegwjvit gcojwpqzox (gppvjuzojn, oefkkwurgi - etzfdwniob) View more | - | 27 Mar 2015 | |||
Not Applicable | - | 30 | (0.01 mmol/kg) | bnaatnkkku(revwvhvgiz) = bdfvalokui tkvznegple (wkcavhluqs, nunirqydow - hdkufmxlke) View more | - | 10 Dec 2013 | |
(0.02 mmol/kg) | bnaatnkkku(revwvhvgiz) = rktzcvaimt tkvznegple (wkcavhluqs, zxhfoqjmxu - vmdkccents) View more | ||||||
Not Applicable | 9 | mjmonckgew(ureenfwxiw) = hbgacjkdrj piyqesldwy (hzrefjudoh ) View more | Positive | 12 Feb 2013 |